NCT02674256View on ClinicalTrials.gov

The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Sensitivity in Healthy Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Sensitivity (Hyper); Gastrointestinal
Interventions
DRUG

CRH

100µg CRH powder for injection (CRH ferring®, Ferring, Aalst, Belgium) and 1 mL of NaCl 0.9% will be put together, then the solution will be injected intravenously over the course of 1 minute

OTHER

Placebo

1 mL of NaCl 0.9% will be injected intravenously over the course of one minute

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02674256 - The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Sensitivity in Healthy Volunteers | Biotech Hunter | Biotech Hunter